STAB1 and neoplasm: Noticeably, mounting evidence from several clinical cohorts and preclinical studies highlights the role of STAB1+ TAMs in mechanisms underlying tumor progression, thereby supporting STAB1 as a potential therapeutic target [7,9,12,14,47,48,50,66,67].